Global Cancer Clinical Decision Tools Market Report 2024

Cancer Clinical Decision Tools Global Market Report 2024 – By Type (Risk Assessment Tool (RAT), Qcancer), By End-User (Hospital, Clinics) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 250 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Cancer Clinical Decision Tools Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Cancer Clinical Decision Tools Market Definition And Segments

Cancer clinical decision tools refer to the tools that are developed to help medical practitioners identify suspected cancer signs and symptoms and treat patients effectively. These tools aid in clinical decision-making by assisting GPs in deciding whether to refer or seek additional diagnostic testing in patients suspected of having cancer.

The main types of cancer clinical decision tools are risk assessment tools (RAT) and Qcancer. By examining a combination of risk factors, including genetic, environmental, and behavioral risk factors, risk assessment tools make it easier to translate these risk models into estimates of an individual’s likelihood of acquiring certain malignancies. The different sectors include hospitals and clinics.

The cancer clinical decision tools market covered in this report is segmented –

1) By Type: Risk Assessment Tool (RAT), Qcancer

2) By End-User: Hospital, Clinics

The cancer clinical decision tools market size has grown rapidly in recent years. It will grow from $0.45 billion in 2023 to $0.5 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to the growing prevalence of cancer, increasing complexity of cancer treatment, rising demand for personalized medicine, growing adoption of value-based healthcare, increasing availability of cancer data, and government support for cancer research and development.

The cancer clinical decision tools market size is expected to see rapidly grown in the next few years. It will grow to $0.72 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to global aging population, patient engagement and shared decision-making, patient-centric care, clinical research and evidence-based medicine. Major trends in the forecast period include advancements in medical imaging, AI-driven clinical decision support, telemedicine and remote consultations, predictive analytics, interoperability and data standards, and ethical and regulatory considerations.

Rise In Cancer Cases Drives Demand For Cancer Clinical Decision Tools

The rise in the number of cancer cases across the globe is likely to contribute to the growth of the cancer clinical decision tools market. For instance, in January 2022, according to the American Cancer Society, there will likely be 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the US, or roughly 1,670 fatalities every day. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43 percent of all new cancer cases. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all new cancer cases. Therefore, the rise in cancer incidence rates across the globe will increase the demand for cancer clinical decision tools to make treatment decisions faster, thereby contributing to the cancer clinical decision tools market growth.

Healthcare It Adoption Boosts Cancer Clinical Decision Tools Market Growth

Growing healthcare IT adoption is expected to drive the cancer clinical decision tools market. Healthcare IT adoption refers to the integration and utilization of information technology solutions in the healthcare sector. Healthcare institutions are strategically investing in information technology, including electronic health records (EHRs) and clinical decision support systems (CDSS), to optimize patient care by seamlessly integrating real-time patient data, treatment guidelines, and alerts for potential issues, thereby enhancing cancer treatment outcomes. For instance, in January 2022, according to a report published by the Healthcare Information and Management Systems Society (HIMSS), a US-based not-for-profit organization, a substantial 80% of healthcare providers had outlined plans to enhance their investments in technology and digital solutions over the next five years. Therefore, growing healthcare IT adoption will drive the cancer clinical decision tools market going forward.

Major companies operating in the cancer clinical decision tools market include McKesson Corporation, Medical Information Technology Inc., Philips Healthcare, Siemens Healthineers AG, Elsevier B.V., Macmillan Publishers Limited, National Decision Support Company, IBM Watson Health, Cerner Corporation, GE Healthcare, Allscripts Healthcare Solutions Inc., Epic Systems Corporation, Koninklijke Philips N.V., RaySearch Laboratories AB, Elekta AB, Varian Medical Systems Inc., Accuray Incorporated, F. Hoffmann-La Roche Ltd., Flatiron Health Inc., Tempus Labs Inc., NantHealth Inc., Syapse Inc., Inspirata Inc., Oncora Medical Inc., Prognos Health Inc., Deep 6 AI Inc., PathAI Inc., Enlitic Inc., Ibex Medical Analytics Ltd., Zebra Medical Vision Ltd., Aidoc Medical Ltd.

Patient Data Breaches Pose A Significant Challenge To The Cancer Clinical Decision Tools Market

The breach of patient data and privacy is a major challenge in the market for cancer clinical decision tools. Hackers can get access to data centers through healthcare employees’ emails, leading to a breach of patients' privacy. For instance, in October 2021, according to Fortune, a US-based publishing company specializing in the publication of books, articles, and magazines, the total number of global data breach cases was 1291 in 2021, up from 1108 in 2020. Phishing and ransomware are the major tools used by cybercriminals, and the total number of data breaches is expected to increase to 17% in 2021. The risk of a loss of data and the privacy of patients harms the growth of the market for cancer clinical decision tools.

Innovative Products Transforming Cancer Clinical Decision Tools Market

Major companies operating in the cancer clinical decision tools market are exploring innovative products such as the BenchMark Ultra Plus tissue staining system to gain a competitive advantage. The BenchMark Ultra Plus system optimizes tissue staining for faster and more accurate pathology results. For instance, in June 2022, F. Hoffmann-La Roche AG, a Switzerland-based healthcare company, launched the BenchMark Ultra Plus tissue staining system, which boasts improved workflow efficiency, testing processes, and sustainability features. This innovative system empowers pathologists to deliver high-quality, time-sensitive results to medical professionals and patients. The BenchMark Ultra Plus system represents the next step in the BenchMark series' evolution, automating previously manual slide-by-slide processes and revolutionizing cancer diagnostics.

NeoGenomics Enhances Cancer Genetics Diagnostic Testing With Acquisition Of Trapelo Health

In March 2021, NeoGenomics Laboratories, Inc., a US-based company that provides clinical laboratories, pharmaceutical services, and information services and focuses on cancer genetics diagnostic testing, acquired Trapelo Health LLC. for an amount of $65 million. Through this acquisition, NeoGenomics would be able to apply precision oncology. To help doctors, labs, and payers choose diagnostics and treatments, enhance clinical trial matching, expedite workflow, and enable real-time alignment with the most recent clinical data, the firm offers a first-of-its-kind, interoperable, decision-support platform. The platform makes it easier for patients to access high-quality, medically acceptable therapy alternatives. This acquisition allows NeoGenomics to utilize a single technological platform developed by Trapelo Health that enables real-time, evidence-based decision assistance, treatment selection, and reimbursement assurance for oncologists, giving patients the best chance to cure cancer. Trapelo Health LLC. is a US-based healthcare technology company specializing in a decision-support platform, order management, and results-reporting solution for molecular testing for cancer.

North America was the largest region in the cancer clinical decision tools market in 2023. The regions covered in the cancer clinical decision tools market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the cancer clinical decision tools market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The market for cancer clinical decision tools consists of sales of risk assessment tools, Q-Cancer tools, and MacMillan’s cancer decision tool. Values in this market are ‘factory gate values,’ that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The cancer clinical decision tools market research report is one of a series of new reports from The Business Research Company that provides cancer clinical decision tools market statistics, including cancer clinical decision tools industry global market size, regional shares, competitors with a cancer clinical decision tools market share, detailed cancer clinical decision tools market segments, market trends and opportunities, and any further data you may need to thrive in the cancer clinical decision tools industry. This cancer clinical decision tools market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Cancer Clinical Decision Tools Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $0.5 billion
Revenue Forecast In 2033 $0.72 billion
Growth Rate CAGR of 9.6% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Risk Assessment Tool(RAT), Qcancer
2) By End-User: Hospital, Clinics
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled McKesson Corporation; Medical Information Technology Inc.; Philips Healthcare; Siemens Healthineers AG; Elsevier B.V.; Macmillan Publishers Limited; National Decision Support Company; IBM Watson Health; Cerner Corporation; GE Healthcare; Allscripts Healthcare Solutions Inc.; Epic Systems Corporation; Koninklijke Philips N.V.; RaySearch Laboratories AB; Elekta AB; Varian Medical Systems Inc.; Accuray Incorporated; F. Hoffmann-La Roche Ltd.; Flatiron Health Inc.; Tempus Labs Inc.; NantHealth Inc.; Syapse Inc.; Inspirata Inc.; Oncora Medical Inc.; Prognos Health Inc.; Deep 6 AI Inc.; PathAI Inc.; Enlitic Inc.; Ibex Medical Analytics Ltd.; Zebra Medical Vision Ltd.; Aidoc Medical Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Cancer Clinical Decision Tools Market Characteristics

    3. Cancer Clinical Decision Tools Market Trends And Strategies

    4. Cancer Clinical Decision Tools Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Cancer Clinical Decision Tools Market Size and Growth

    5.1. Global Cancer Clinical Decision Tools Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Cancer Clinical Decision Tools Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Cancer Clinical Decision Tools Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Cancer Clinical Decision Tools Market Segmentation

    6.1. Global Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Risk Assessment Tool(RAT)

    Qcancer

    6.2. Global Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital

    Clinics

    7. Cancer Clinical Decision Tools Market Regional And Country Analysis

    7.1. Global Cancer Clinical Decision Tools Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Cancer Clinical Decision Tools Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Cancer Clinical Decision Tools Market

    8.1. Asia-Pacific Cancer Clinical Decision Tools Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Cancer Clinical Decision Tools Market

    9.1. China Cancer Clinical Decision Tools Market Overview

    9.2. China Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Cancer Clinical Decision Tools Market

    10.1. India Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Cancer Clinical Decision Tools Market

    11.1. Japan Cancer Clinical Decision Tools Market Overview

    11.2. Japan Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Cancer Clinical Decision Tools Market

    12.1. Australia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Cancer Clinical Decision Tools Market

    13.1. Indonesia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Cancer Clinical Decision Tools Market

    14.1. South Korea Cancer Clinical Decision Tools Market Overview

    14.2. South Korea Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Cancer Clinical Decision Tools Market

    15.1. Western Europe Cancer Clinical Decision Tools Market Overview

    15.2. Western Europe Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Cancer Clinical Decision Tools Market

    16.1. UK Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Cancer Clinical Decision Tools Market

    17.1. Germany Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Cancer Clinical Decision Tools Market

    18.4. France Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.5. France Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Cancer Clinical Decision Tools Market

    19.7. Italy Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.8. Italy Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Cancer Clinical Decision Tools Market

    20.10. Spain Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.11. Spain Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Cancer Clinical Decision Tools Market

    21.1. Eastern Europe Cancer Clinical Decision Tools Market Overview

    21.2. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Cancer Clinical Decision Tools Market

    22.1. Russia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Cancer Clinical Decision Tools Market

    23.1. North America Cancer Clinical Decision Tools Market Overview

    23.2. North America Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Cancer Clinical Decision Tools Market

    24.1. USA Cancer Clinical Decision Tools Market Overview

    24.2. USA Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Cancer Clinical Decision Tools Market

    25.1. Canada Cancer Clinical Decision Tools Market Overview

    25.2. Canada Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Cancer Clinical Decision Tools Market

    26.1. South America Cancer Clinical Decision Tools Market Overview

    26.2. South America Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Cancer Clinical Decision Tools Market

    27.1. Brazil Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Cancer Clinical Decision Tools Market

    28.1. Middle East Cancer Clinical Decision Tools Market Overview

    28.2. Middle East Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Cancer Clinical Decision Tools Market

    29.1. Africa Cancer Clinical Decision Tools Market Overview

    29.2. Africa Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Cancer Clinical Decision Tools Market Competitive Landscape And Company Profiles

    30.1. Cancer Clinical Decision Tools Market Competitive Landscape

    30.2. Cancer Clinical Decision Tools Market Company Profiles

    30.2.1. McKesson Corporation

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Medical Information Technology Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Philips Healthcare

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Siemens Healthineers AG

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Elsevier B.V.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Cancer Clinical Decision Tools Market Competitive Benchmarking

    32. Global Cancer Clinical Decision Tools Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Cancer Clinical Decision Tools Market

    34. Cancer Clinical Decision Tools Market Future Outlook and Potential Analysis

    34.1 Cancer Clinical Decision Tools Market In 2028 - Countries Offering Most New Opportunities

    34.2 Cancer Clinical Decision Tools Market In 2028 - Segments Offering Most New Opportunities

    34.3 Cancer Clinical Decision Tools Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Cancer Clinical Decision Tools Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Cancer Clinical Decision Tools Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Asia-Pacific, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: China, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: China, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: India, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: India, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: Japan, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: Japan, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: Australia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: Australia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Indonesia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Indonesia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: South Korea, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: South Korea, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Western Europe, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Western Europe, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: UK, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: UK, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Germany, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Germany, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: France, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: France, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Italy, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Italy, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Spain, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Spain, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Eastern Europe, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: Eastern Europe, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Russia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Russia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: North America, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: North America, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: USA, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: USA, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Canada, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Canada, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: South America, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: South America, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Brazil, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Brazil, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Middle East, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Middle East, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Africa, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Africa, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: McKesson Corporation Financial Performance
  • Table 52: Medical Information Technology Inc. Financial Performance
  • Table 53: Philips Healthcare Financial Performance
  • Table 54: Siemens Healthineers AG Financial Performance
  • Table 55: Elsevier B.V. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Cancer Clinical Decision Tools Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Cancer Clinical Decision Tools Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Asia-Pacific, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: China, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: China, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: India, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: India, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: Japan, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: Japan, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: Australia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: Australia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Indonesia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Indonesia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: South Korea, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: South Korea, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Western Europe, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Western Europe, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: UK, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: UK, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Germany, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Germany, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: France, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: France, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Italy, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Italy, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Spain, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Spain, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Eastern Europe, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: Eastern Europe, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Russia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Russia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: North America, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: North America, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: USA, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: USA, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Canada, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Canada, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: South America, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: South America, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Brazil, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Brazil, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Middle East, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Middle East, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Africa, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Africa, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: McKesson Corporation Financial Performance
  • Figure 52: Medical Information Technology Inc. Financial Performance
  • Figure 53: Philips Healthcare Financial Performance
  • Figure 54: Siemens Healthineers AG Financial Performance
  • Figure 55: Elsevier B.V. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the cancer clinical decision tools market?

Cancer clinical decision tools refer to the tools that are developed to help medical practitioners identify suspected cancer signs and symptoms and treat patients effectively. These tools aid in clinical decision-making by assisting GPs in deciding whether to refer or seek additional diagnostic testing in patients suspected of having cancer. For further insights on the cancer clinical decision tools market, request a sample here

How will the cancer clinical decision tools market drivers and restraints affect the cancer clinical decision tools market dynamics? What forces will shape the cancer clinical decision tools industry going forward?

The cancer clinical decision tools market growth is aided by rise in the number of cancer cases across the globe. However, some cancer clinical decision tools market restraints include breach of patient data and privacy. For further insights on the cancer clinical decision tools market, request a sample here

What is the forecast market size or the forecast market value of the cancer clinical decision tools market?

The cancer clinical decision tools market is expected to reach $0.65 billion in 2027 at a rate of 9.9%. For further insights on the cancer clinical decision tools market, request a sample here

How is the cancer clinical decision tools market segmented?

The global cancer clinical decision tools market is segmented as
1) By Type: Risk Assessment Tool(RAT), Qcancer
2) By End-User: Hospital, Clinics
For further insights on the cancer clinical decision tools market,
request a sample here

Which region has the largest share of the cancer clinical decision tools market? What are the largest region's market size and growth rate?

North America was the largest region in the cancer clinical decision tools market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here.

Who are the major players in the cancer clinical decision tools market?

Key competitors in the cancer clinical decision tools market are, McKesson Corporation, Medical Information Technology Inc., Philips Healthcare, Siemens Healthineers, Elsevier B.V., Macmillan, National Decision Support Company. For further insights on the cancer clinical decision tools market, request a sample here.

What are the key trends in the cancer clinical decision tools market?

For further insights on the cancer clinical decision tools market, request a sample here.

What are the major opportunities in the cancer clinical decision tools market? What are the strategies for the cancer clinical decision tools market?

For detailed insights on the major opportunities and strategies in the cancer clinical decision tools market, request a sample here.

How does the cancer clinical decision tools market relate to the overall economy and other similar markets?

For detailed insights on cancer clinical decision tools market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the cancer clinical decision tools industry?

For detailed insights on the mergers and acquisitions in the cancer clinical decision tools industry, request a sample here.

What are the key dynamics influencing the cancer clinical decision tools market growth? SWOT analysis of the cancer clinical decision tools market.

For detailed insights on the key dynamics influencing the cancer clinical decision tools market growth and SWOT analysis of the cancer clinical decision tools industry, request a sample here.